Interim report
Page 1
October 30, 2026 To, Listing Department National Stock Exchange of India Limited Exchange Plaza Bandra-Kurla Complex, Bandra (East) Mumbai – 400 051 Symbol: MEDIASSIST Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001 Scrip Code: 544088 Dear Sir/ Madam, Subject: Outcome of the Board Meeting – October 30, 2026 The Board of Directors of Medi Assist Healthcare Services Limited (the “Company”) in their meeting held today i.e., October 30, 2026, have inter-alia, approved the following: 1) Unaudited Financial Results (Standalone and Consolidated) for the quarter & half year ended September 30, 2026 Approved unaudited financial results (standalone and consolidated) of the Company for the quarter & half year ended September 30, 2026. Copy of the unaudited financial results (standalone and consolidated) for the quarter & half year ended September 30, 2026 along with Limited Review Report issued by the Statutory Auditors of the Company are enclosed herewith as Annexure A. 2) Buyback of fully-paid up equity shares of the Company through the “tender offer” route The buyback of upto 11,59,199 (Eleven Lakh Fifty Nine Thousand One Hundred Ninety Nine) fully paid- up equity shares of the Company having a face value of INR 5/- (Indian Rupees Five only) each of the Company (“Equity Shares”), at a price of INR 425/- (Indian Rupees Four Hundred Twenty Five only) per Equity Share (“Buyback Price”) payable in cash for an amount not exceeding INR 49,26,59,575/- (Indian Rupees Forty Nine Crore Twenty Six Lakh Fifty Nine Thousand Five Hundred Seventy Five only) (“Buyback Size”), which is within the limit of 10% of the aggregate of the total paid-up Equity Share capital and free reserves of the Company under the Board approval route as per the Companies Act, 2013 and the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (the “SEBI Buyback Regulations”), on a proportionate basis through the “tender offer” route, using the stock exchange mechanism for acquisition of shares as prescribed under the SEBI Buyback Regulations and such other circulars or notifications issued by the Securities and Exchange Board of India (“SEBI”) and the Companies Act, 2013 and rules made thereunder, as amended from time to time, from all the shareholders/ beneficial owners of the Equity Shares (“Buyback”). The Buyback Size does not include transaction costs viz. brokerage costs, fees, turnover charges, applicable taxes such as securities transaction tax, goods and service tax, stamp duty, any expenses incurred or to be incurred for the Buyback like filing fees payable, advisors, legal fees, intermediary fees, public announcement publication expenses, printing, dispatch expenses and other incidental and related expenses.
Page 2
3) The Company has constituted a committee called “Buyback Committee” and delegated its powers to do such acts, deeds, matters, and things as it may, in its absolute discretion, deem necessary, expedient, usual or proper in relation to the proposed Buyback. 4) Pursuant to Regulation 42 of the SEBI Listing Regulations and Regulation 9(i) of the SEBI Buyback Regulations, the Company has fixed Friday, November 20, 2026 as the record date (“Record Date”) for determining entitlement and the names of the equity shareholders who shall be eligible to participate in the Buyback. 5) The Board/ Buyback Committee may, 1 (one) working day prior to the Record Date, increase the Buyback Price and decrease the number of Equity Shares proposed to be bought back under the Buyback, such that there is no change in the Buyback Size, in terms of Regulation 5(via) of the SEBI Buyback Regulations. 6) The Board has noted the intention of the promoter and members of the promoter group of the Company, to not participate in the Buyback. 7) The Board has appointed, Ms. Rashmi BV, Company Secretary, as the compliance officer for the purposes of the proposed Buyback. The process, record date, timelines and other requisite details with respect to the Buyback will be set out in the public announcement and the letter of offer to be published in accordance with the SEBI Buyback Regulations. The details as required under Regulation 30 of SEBI Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD/2/1/3762/2026 dated January 30, 2026, is set out in Annexure B. The Board Meeting commenced at 9.00 a.m. (IST) and concluded at 5.20 p.m. (IST). The trading window for dealing in shares of the Company is closed from October 01, 2026 till November 01, 2026. This outcome shall also be made available on the Company’s website at www.mediassist.in You are requested to take the same on record. Yours faithfully, For Medi Assist Healthcare Services Limited Rashmi B V Company Secretary & Compliance Officer ICSI Membership No: A38729 Encl.: As above
Page 3
MS K A Et Associates LLP (Formerly known as MS K A & Associates) Chartered Accountants SV Tower, No. 27, Floor 4 80 Feet Road, 6th Block, Koramangala Bengaluru 560095, INDIA Independent Auditor's Review Report on consolidated unaudited financial results of Medi Assist Healthcare Services Limited for the quarter and year-to-date pursuant to the Regulation 33 of the SEW (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Medi Assist Healthcare Services Limited 1. We have reviewed the accompanying Statement of consolidated unaudited financial results of Medi Assist Healthcare Services Limited (hereinafter referred to as 'the Holding Company') and its subsidiaries, (the Holding Company and its subsidiaries together referred to as the 'Group') for the quarter ended September 30, 2026 and the year to-date results for the period from April 01, 2026 to September 30, 2026 ('the Statement') attached herewith, being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('the Regulations'). 2. This Statement, which is the responsibility of the Holding Company's Management and approved by the Holding Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting' prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with relevant rules issued thereunder ('Ind AS 34') and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the Securities and Exchange Board of India under Regulation 33 (8) of the Regulations, to the extent applicable. Page 1 of 3 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 LLPTN: ACT-3789 Ahmedabad I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi I Kolkata I Mumbai I Pune www.mska.in
Page 4
MS K A Et Associates LLP (Formerly known as MS K A Et Associates) Chartered Accountants 4. This Statement includes the results of the Holding Company and the following entities: Sr. No Name of the Entity Relationship with the Holding Company 1 Medi Assist Insurance TPA Private Limited Wholly owned subsidiary 2 International Healthcare Management Services Private Limited Wholly owned subsidiary 3 Mayfair Consultancy Services India Private Limited Wholly owned subsidiary 4 Mayfair We Care Limited Subsidiary 5 Mayfair We Care Philippines Inc Stepdown subsidiary 6 Mayfair We Care Pte Limited Stepdown subsidiary 7 Paramount Health Services and Insurance TPA Private Limited Stepdown subsidiary 5. Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the consideration of the review reports of the other auditors referred to in paragraph 7, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 6. Emphasis of Matter We draw attention to Note 7 to the accompanying Statement which describes that search and seizure operation was carried out by the Directorate of Enforcement at certain offices of a wholly owned subsidiary and the management's assessment thereof about the consequent impact on the Statement. Our conclusion is not modified in respect of this matter. Page 2 of 3 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 I LLPIN. ACT-3789 Ahmedabad 1 Chandigarh 1 Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi 1 Kolkata I Mumbai I Pune www.mska.in
Page 5
MS K A Et Associates LLP (Formerly known as MS K A EL Associates) Chartered Accountants 7. We did not review the interim financial information of one subsidiary and three step down subsidiaries included in the Statement, whose interim financial information reflect total assets of Rs. 1,055.95 million as at September 30, 2026 and total revenues of Rs. 106.53 million and Rs. 207.20 million, total net profit after tax of Rs. 7.52 million and Rs. 47.66 million and total comprehensive income of Rs. 14.74 million and Rs. 57.15 million, for the quarter ended September 30, 2026 and for the period from April 01, 2026 to September 30, 2026, respectively, and cash Inflow (net) of Rs. 67.35 million for the period from April 01, 2026 to September 30, 2026, as considered in the Statement. These interim financial information have been reviewed by other auditors whose reports have been furnished to us by the Management and our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries, is based solely on the report of the other auditors and the procedures performed by us as stated in paragraph 3 above. Our conclusion is not modified in respect of the above matter with respect to our reliance on the work done by and report of the other auditors. For M S K A& Associates LLP (Formerly known as M S K A& Associates) Chartered Accountants ICAI Firm Registration No.105047W/W101187 Pankaf S Bhauwala Partner Membership No.: 233552 UDIN: 26233552WDQH6X6606 Place: Bengaluru Date: October 30, 2026 Page 3 of 3 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 LLPIN: ACT-3789 Ahmedabad I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi I Kolkata I Mumbai I Pune www.mska.in
Page 6
Medi Assist Healthcare Services Limited Corporate Identity Number: L74900MH2000PLC437885 Registered office: AARPEE Chambers, SSRP Building, 7th Floor. Marol Co-operative Industrial Estate Road, Gamdevi, Marol, Andheri East, Mumbai - 400059, India. Telephone .: 91- 8069190000, E-mail: aslaimediassistin. website: www.mediassist.in Statement of unaudited consolidated financial results for the quarter and six months ended 30 September 2026 (Rs. in millions unless otherwise stated) Sr. No. Particulars Quarter ended Six months ended Vear ended 30 September 2026 30 June 2026 30 September 2025 30 September 2026 30 September 2025 31 March 2026 1 ' naudited Unaudited Unaudited Unaudited Unaudited Audited (refer note 3) 1 Income Revenue from operations 2,415.10 2,365.19 2,325.45 4,780.29 4,231.03 9,047.67 Other income 38.51 104.97 22.75 143.48 96.67 196.36 Total income 2,453.61 2,470.16 2,348.20 4,923.77 4,327.70 9,244.03 2 Expenses Employee benefits expense 1,035.87 1,032.60 1,054.50 2,068.47 1,853.14 3,940.72 Finance costs 15.58 17.59 75.93 33.17 123.73 225.71 Depreciation and amortisation expenses 217.91 218.47 209.32 436.38 350.44 771.25 Other expenses 886.93 852.43 873.77 1,739.36 1,560.59 3,360.88 Total expenses 2,156.29 2,121.09 2,213.52 4,277.38 3,887.90 8,298.56 3 Profit before exceptional items and tax (1-2) 297.32 349.07 134.68 646.39 439.80 945.47 4 - Exceptional items (refer note 9) 141.95 - - - - 5 Profit before tax for the period/ year (3-4) 297.32 349.07 13-4.68 646.39 439.80 803.52 6 Income tax expense: Current tax 88.63 32.92 88.04 121.55 190.76 318.74 Adjustment for current tax relating to earlier years 5.22 5.22 12.81 Deferred tax expense/ (credit) (refer note 10) (7.07) 40.18 (39.25) 33.11 (63.16) (421.14) Total income tax expense 81.56 73.10 54.01 154.66 132.82 (89.59) 7 Profit for the period/ year (5-6) 215.76 275.97 80.67 491.73 306.98 893.11 8 Other comprehensive income/(loss) Items that will not be reclassified subsequently to statement of profit and loss Re-measurement of gains/(losses) on defined benefit plans 0.88 (0.98) 14.93 (0.10) 5.85 (9.43) Fair value changes in equity instruments through other comprehensive income (1.26) 6.89 (5.06) 5.63 0.04 (0.12) Income tax relating to items that will not be reclassified to statement of profit and loss 0.05 0.85 (1.10) 0.90 0.49 1.59 Item that will be reclassified to statement of profit and loss in subsequent periods Exchange differences on translation of foreign operations 10.12 4.20 6.29 14.32 20.50 34.69 Total other comprehensive income/(loss) for the period/ year, net of tax 9.79 10.96 15.06 20.75 26.88 26.73 9 Total comprehensive income for the period/ year 225.55 286.93 95.73 512.48 333.86 919.84 (7+8) (Page 1 of 7)
Page 7
Medi Assist Healthcare Services Limited Corporate Identity Number: L74900MH2000PLC437885 Registered office: AARPEE Chambers, SSRP Building, 7th Floor, Marol Co-operative Industrial Estate Road, Gamdevi, Marol, Andheri East, Mumbai - 400059, India. Telephone.: 91- 8069190000. E-mail: askjmediassist.in; website: www.mediassist.in Statement of unaudited consolidated financial results for the quarter and six months ended 30 September 2026 (Rs. in millions unless otherwise stated) Sr. No. Particulars Quarter ended Six months ended Year ended 30 September 2026 30 June 2026 30 September 2025 30 September 2026 30 September 2025 31 March 2026 Unaudited Unaudited Unaudited Unaudited Unaudited Audited (refer note 3) 10 Profit for the period/ year attributable to: Owners of the Company 215.18 276.84 79.46 492.02 303.43 878.89 Non-controlling interest 0.58 (0.87) 1.21 (0.29) 3.55 14.22 Profit for the period/ year 215.76 275.97 80.67 491.73 306.98 893.11 II Other comprehensive income/ (loss) for the period/ year attributable to: Owners of the Company 8.95 9.28 12.54 18.24 18.68 12.85 Non-controlling interest 0.84 1.68 2.52 2.51 8.20 13.88 Other comprehensive income/ (loss) for the period! year 9.79 10.96 15.06 20.75 26.88 26.73 12 Total comprehensive income for the period/ year attributable to: Owners of the Company 224.14 286.12 92.00 510.26 322.11 891.75 Non-controlling interest 1.41 0.81 3.73 2.22 11.75 28.09 Total comprehensive income for the period/ year 225.55 286.93 95.73 512.48 333.86 919.84 13 Paid up equity share capital (face value of Rs. 5 each) 373.51 373.51 353.25 373.51 353.25 373.05 14 Other equity 8,015.98 15 Earnings per equity share (face value of Rs. 5 each) (not annualised except for the year ended 31 March 20261 Basic (Rs) 2.88 3.71 1 13 6.59 4.30 12.14 Diluted (Rs) 2.88 3.71 1.12 6.59 4.28 12.14 (Page 2 of 7)
Page 8
Medi Assist Healthcare Services Limited Corporate Identity Number: L74900MH2000PLC437885 Registered office: AARPEE Chambers, SSRP Building, 7th Floor, Marol Co-operative Industrial Estate Road. Gamdevi, Marol, Andheri East, Mumbai - 400059, India. Telephone .: 91- 8069190000, E-mail: ask'mediassist.in: website: NNANy. mediassist in U naudited Consolidated Statement of Assets and Liabilities (Rs. in millions unless otherwise stated) Sr. No. Particulars As at 30 September 2026 (Unaudited) As at 31 March 2026 (Audited) (refer note 3) A. ASSETS I Non-current assets Property, plant and equipment 396.87 434.83 Right-of-use assets 408.21 502.25 Goodwill 3,518.82 3,514.40 Other intangible assets 1,978.28 1,941.22 Intangible assets under development 36.46 194.40 Financial assets Investments 58.22 52.07 Other financial assets 451.13 278.12 Income tax assets (net) 898.31 673.63 Deferred tax assets (net) 237.28 269.80 Other non-current assets 6.32 12.11 Total non-current assets 7,989.90 7,872.83 2 Current assets Financial assets Investments 1,155.86 1,527.55 Trade receivables 3,589.18 2,866.82 Cash and cash equivalents 503.02 546.32 Bank balances other than cash and cash equivalents above 634.59 317.06 Other financial assets 216.40 157.94 Other current assets 325.69 436.10 Total current assets 6,424.74 5,851.79 Total assets 14,414.64 13,724.62 B. EQUITY AND LIABILITIES 1 EQUITY Equity share capital 373.51 373.05 Other equity 8.464.75 8,015.98 Equity attributable to owners of the Company 8,838.26 8,389.03 Non-controlling interests 29.42 134.97 Total equity 8,867.68 8,524.00 LIABILITIES 2 Non-current liabilities Financial liabilities Lease liabilities 261.03 375.75 Other financial liabilities 19.08 76.28 Provisions 350.49 372.18 Total non-current liabilities 630.60 824.21 3 Current liabilities Financial liabilities Lease liabilities 200.15 168.23 Trade payables Total outstanding dues of micro enterprises and small enterprises: and 113.74 130.93 Total outstanding dues of creditors other than micro enterprises and small enterprises 260.98 325.08 Other financial liabilities 575.73 595.04 Contract liabilities 3,216.76 2,801.90 Other current liabilities 222.95 98.63 Provisions 221.49 230.50 Current tax liabilities (net) 104.56 26.10 Total current liabilities 4,916.36 4,376.41 Total liabilities 5,546.96 5,200.62 Total equity and liabilities 14,414.64 13,724.62 (Page 3 of 7)
Page 9
Medi Assist Healthcare Services Limited Corporate Identity Number: L74900MH2000PLC437885 Registered office: AARPEE Chambers. SSRP Building, 7th Floor, Marol Co-operative Industrial Estate Road, Gamdevi, Marol, Andheri East, Mumbai - 400059, India. Telephone 91- 8069190000, E-mail: ask@mediassist.in: website: w'v's. mediassist.in Unaudited Consolidated Statement of Cash Flows (Rs. in millions unless otherwise stated) Particulars For the six months ended 30 September 2026 (Unaudited) For the six months ended 30 September 2025 (Unaudited) Cash flows from operating activities Profit before tax for the period 646.39 439.80 Adjustment: Depreciation and amortisation expenses 436.38 350.44 Allowance for expected credit losses on trade receivables 14.95 29.24 Provision for doubtful advances and other receivables 21.18 9.69 Creditors/ provisions no longer required written back (0.83) (0.03) (Gain)/ loss on modification of lease contracts 1.14 (0.11) Employee stock option compensation expense 13.28 19.64 Finance costs 32.17 123.73 Profit on sale of investments in mutual funds (77.38) (89.36) Interest income (28.08) (30.62) Net loss on financial assets measured at fair value through profit and loss - 31.98 (Profit)/ loss on disposal of property, plant and equipment (net) 0.15 (0.32) Fair value gain on derivative asset (31.18) Net foreign exchange differences (unrealised) (4.42) 6.60 Operating profit before working capital changes 1,023.75 890.68 Working capital adjustments: (Decrease) in trade payables (74.53) (112.74) (Decrease)/ increase in other liabilities 453.98 76.71 (Decrease)/ increase in provisions (30.60) 74.41 (Increase) in trade receivables (737.31) (806.69) Decrease in other assets 31.54 151.80 Cash generated from operations 666.83 274.17 Income taxes paid (net) (265.38) (404.66) Net cash flows from operating activities (A) 401.45 (130.49) Cash flows from investing activities Purchase of property, plant and equipment, other intangible assets including intangible under development and capital advances (268.06) (267.44) (Purchase) of/ proceeds from sale of non-current investments (net) (0.52) (45.28) Payment for acquisition of subsidiaries, net of cash acquired - (4,018.50) Proceeds from/ (purchase) of investments in mutual funds (net) 449.07 2,997.83 (Investment)/ redemption of bank deposits and other bank balances (486.79) 422.22 Interest received 17.65 27.21 Net cash flows (used in) investing activities (B) (288.65) (883.95) Cash flows from financing activities Proceeds from issue of shares (including share premium) on exercise of employee stock option 23.97 39.76 Finance costs paid - (90.20) Proceeds from non-current borrowings - 2,432.12 (Repayment) of short term borrowings - (1,549.27) Acquisition of non-controlling interest (76.22) - Payment of lease liabilities (118.17) (96.74) Net cash flows from financing activities (C) (170.42) 735.67 Net increase/ (decrease) in cash and cash equivalents (A+B+C) (57.62) (278.77) Cash and cash equivalents at the beginning of the period 546.32 830.14 Effects of movements in exchange rates on cash and cash equivalents 14.32 6.42 Cash and cash equivalents at the end of the period 503.02 557.79 Component of cash and cash equivalents Balances with banks - In current accounts 300.20 531.52 - In deposits with original maturity of less than three months 202.81 23.93 Cash on hand 0.01 2.34 Total cash and cash equivalents at the end of the period 503.02 557.79 (Page 4 of 7)
Page 10
Notes to statement of unaudited consolidated financial results for the quarter and six months ended 30 September 2026 1 In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the above unaudited consolidated financial results of Medi Assist Healthcare Services Limited ("the Holding Company" or "the Company"), its subsidiaries (the Holding Company along with subsidiaries together referred to as "the Group") have been reviewed and recommended by the Audit Committee and approved by the Board of Directors, at their meetings held on 29 October 2026 and 30 October 2026 respectively. These unaudited consolidated financial results have been subjected to limited review by the Statutory auditors of the Company and they have issued an unmodified review report on these unaudited consolidated financial results. 2 The above unaudited consolidated financial results for the quarter and six months ended 30 September 2026 have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015, as amended, ("Ind AS") prescribed under section 133 of the Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable. 3 The figures for the year ended 31 March 2026 have been extracted from the general purpose consolidated financial statements of the Company for the year ended 31 March 2026 which have been audited by the Statutory auditors of the Company. 4 The Company is engaged in the business of providing health management services which is determined to be the only reportable segment in terms of Ind AS 108 " Operating Segments". 5 On 26 August 2024, Medi Assist Insurance TPA Private Limited ("Transferee Company"/"MAITPA"), the wholly owned subsidiary of the Company had entered into Share Purchase Agreement ("SPA") with Paramount Health Services and Insurance TPA Private Limited ("Transferor Company"/"Paramount TPA") and the Shareholders of the Transferor Company, to purchase 100% equity shares of Transferor Company at a total enterprise value of Rs. 3,118.00 million (Rupees three thousand one hundred eighteen million only) (subject to closing adjustments) which is subject to fulfilment of conditions precedent as defined in the SPA. Regulatory approval from Insurance Regulatory and Development Authority of India (IRDAI) was received on 13 May 2025. On 01 July 2025, the MAITPA had completed acquisition of 100% equity stake in Paramount TPA upon payment of the purchase consideration of Rs. 4,124.40 million after closing adjustments as per SPA, and the share transfer was duly executed. Consequently, Paramount TPA became a wholly. owned subsidiary of MAITPA and step-down subsidiary of the Company. 6 This statement includes the results of the Holding Company and the following entities: SI Name of the Entity Relationship with the Holding Company I Medi Assist Insurance TPA Private Limited Wholly owned subsidiary 2 International Healthcare Management Services Private Limited (refer to note II) Wholly owned subsidiary 3 Mayfair Consultancy Services India Private Limited (refer to note II) Wholly owned subsidiary 4 Mayfair We Care Limited (refer to note 12) Subsidiary 5 Mayfair We Care Philippines Inc Stepdown subsidiary 6 Mayfair We Care Pte Limited Stepdown subsidiary 7 Paramount Health Services and Insurance TPA Private Limited Stepdown subsidiary 7 During the previous year ended 31 March 2026, on 04 April 2025, the Enforcement Directorate (the "ED") conducted a search and seizure operation at certain offices of MAITPA, located in Ranchi, Jharkhand. MAITPA is one of the third-party administrators (TPAs) engaged in administering the Ayushman Bharat-linked health scheme in the state of Jharkhand. MAITPA has fully co-operated with the officials during the proceedings and responded to the clarifications and details sought by them. As on the date of issuance of these consolidated financial results, MAITPA has not received any communication from the ED regarding the outcome of the search. The Management, after considering all available records and facts known to it, is of the view that there is no adverse impact on the Group, and no adjustment is required in these consolidated financial results for the quarter and six months ended 30 September 2026 in this regard. 8 The Board of Directors of the Company at its meeting held on 07 August 2025 approved the issuance of equity shares by way of preferential allotment and constitution of Fund Raising Committee. The same was subsequently approved by the Shareholders of the Company at the Extraordinary General Meeting of the Company ( 1EGNT) held on 04 September 2025. Pursuant to the above approvals, on 10 October 2025, Fund Raise Committee allotted 37,01,000 (Thirty Seven Lakh and One Thousand) fully paid-up equity shares of face value Rs. 5 each at a price of Rs. 535 per share (including a share premium of Rs. 530 per share), for an aggregate consideration of Rs. 1,98,00,35,000 (Rupees One Hundred Ninety-Eight Crore and Thirty-Five Thousand only). The equity shares were allotted on a private placement basis to identified investors as per the details set forth below: Name of Allottees Category Number of shares issued Price at which equity shares are issued (including a share premium of Rs. 530 per share) Consideration received as on the date of allotment (Rs. million) Massachusetts Institute of Technology Non- promoter 28,90,830 535 1,546.59 238 Plan Associates LLC Non- promoter 8,10,170 535 433.44 Total 37,01,000 1,980.03 The net proceeds from the above were utilized for the purposes as stated in the Offer documents other than Rs. 420.26 million which is lying unspent as of 30 September 2026. In accordance with Ind AS 32, the costs that are directly attributable to the above transactions, have been adjusted in equity. (Page 5 of 7)
Page 11
Notes to statement of unaudited consolidated financial results for the quarter and six months ended 30 September 2026 9 Exceptional items (a) During the year ended 31 March 2026, Paramount TPA, a material step-down subsidiary of the Company, experienced a cyber-security incident that impacted certain systems and services. The incident was fully contained at the Paramount TPA level and did not affect the Company or any of its other subsidiaries. The Company had reported to and intimated the relevant authorities including the stock exchanges of this event. Pursuant to the above, Paramount TPA undertook certain security and business continuity measures including engaging external experts to support system restoration, cyber-forensic activities, etc. Towards these measures, Paramount TPA incurred costs amounting to Rs. 37.68 million up to 31 March 2026 and these have been presented as an exceptional item in the consolidated financial results for the year ended 31 March 2026. Additionally, Paramount TPA has lodged an insurance claim under its cyber-insurance policy for recovery of the eligible costs incurred towards the above incident. The Management, after considering all available information believes no additional adjustments are considered necessary in the consolidated financial results for the quarter and six months ended 30 September 2026. (b) Effective 21 November, 2025, the Government of India consolidated 29 existing labour regulations into four Labour codes, namely, The Code on Wages, 2019, The Industrial Relations Code, 2020, The Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes'. The New Labour Codes has resulted in material increase in provision for employee benefits on account of recognition of past service costs. Based on the requirements of New Labour Codes, internal management assessment, actuary report and the best information available, accounting standards and in line with !CAI guidance, the Group had assessed and accounted the estimated incremental impact of Rs. 33.27 million as Exceptional Item in the consolidated financial results for the year ended 31 March 2026. (c) During the year ended 31 March 2026, pursuant to a claim received by MAITPA from its customer (insurance company), towards claims disallowed for claims alleged to be processed by MA1TPA. In line with the past practices, MAITPA made on account payments to the insurance company pending review and reconciliation of these claims aggregating to Rs. 71.00 million. Further, MAITPA had performed an internal evaluation and assessment, basis which management is of the view that there will not be any adjustments towards recoveries for the aforementioned advances paid and are eligible for a full recovery of advance paid to the customer, however as the discussion with the customer are ongoing and the Group is yet to receive adequate and complete information from the customer to conclude the settlement, on a prudent basis the Group has made a full provision amounting to Rs. 71.00 million towards the net advance paid and disclosed this as an exceptional item. The Group has initiated steps to recover the funds and after considering all available information believes no additional adjustments are considered necessary in the consolidated financial results for the quarter and six months ended 30 September 2026. 10 During the year ended 31 March 2026, MAITPA and Paramount TPA in the meetings of their respective Board of Directors held on 29 December 2025, had considered and approved the Scheme of Amalgamation/merger of Paramount TPA with MAITPA under the provisions of Section 233 of the Companies Act, 2013 and the rules made thereunder. Subsequently, the Board of Directors of MAITPA and Paramount TPA, at the respective meetings held on 06 February 2026, had approved the withdrawal of the aforementioned merger, and in place of the above, noted and approved the transfer of the TPA business of Paramount TPA w.e.f 01 February 2026, to MAITPA, by way of a Business Transfer Agreement ('BTA'), the BTA constituted transfer of all assets and liabilities relating to the TPA business except for certain balances including treasury assets by way of slump transfer for nil consideration. Consequently, the appropriate adjustments including relating to adjustment of deferred tax balances amounting to Rs. 328.68 million have been appropriately considered in these consolidated financial results. Further the Board of Directors of MAITPA and Paramount TPA, at the their respective meetings held on 06 February 2026, had considered and approved a Scheme of Merger by Absorption of Paramount TPA ("Transferor Company") with the Company ("Transferee Company") and their respective shareholders and creditors, pursuant to the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ("Scheme"), subject to receipt of requisite statutory, regulatory and other approvals, as applicable. During the quarter and six months ended 30 September 2026, The Insurance Regulatory and Development Authority of India (IRDAI) has sought certain clarifications in relation to the aforesaid matter, to which MAITPA and Paramount TPA have submitted a joint response. 11 During the year ended 31 March 2026, the Board of Directors of International Healthcare Management Services Private Limited, wholly owned subsidiary, ("IHMS"/"Transferor Company") and Mayfair Consultancy Services India Private Limited, wholly owned subsidiary, ("MCSI"/"Transferee Company") approved, at their respective meetings held on 06 February 2026, a Scheme of Amalgamation/merger of IHMS with MCSI under Section 233 of the Companies Act, 2013, with an appointed date of 01 April 2025. The Scheme was filed with the Regional Director ("RD"). who forwarded the application to the Hon'ble National Company Law Tribunal, Bengaluru Bench ("Hon'ble NCLT"), vide order dated 19 May 2026, under Section 233(5) for its consideration. During the quarter ended 30 June 2026, the Hon'ble NCLT Registry sought additional documents/information, which the Companies have furnished. The matter is pending before the Hon'ble NCLT for issuance of notice and further directions as on date. (Page 6 017)
Page 12
Place: Bengaluru Date: 30 October 2026 Initialed For Identification Purposes Only For and on behalf of the Board of Directors of Medi Assist Healthcare Services Limited CIN: L74900MH2000PLC4378 5 Satish Gidugu CFO and Whole Time Director DIN: 06643677 (Page 7 of 7) Notes to statement of unaudited consolidated financial results for the quarter and six months ended 30 September 2026 12 During the quarter ended 30 June 2026, in accordance with the terms of the Shareholder's Agreement ("SHA"), the Company exercised its contractual option to acquire an additional 31.75% equity stake in Mayfair We Care Limited, which was approved by the Board of Directors vide its meeting held on 24 June 2026. In connection with the proposed acquisition, the Company paid an advance of Rs. 47.17 million on 30 June 2026 and a further sum of Rs. 28.51 million on 01 July 2026 and completed the acquisition of aforementioned stake effective 01 July 2026. Consequently the Group's stake in Mayfair We Care UK is now revised to 91.75%. 13 The Board of Directors of the Company, at its meeting held on 30 October 2026, approved a proposal to buyback up to 11,59,199 fully paid-up equity shares of the Company having a face value of [(Rs 5/- (Five only)] each of the Company ("Equity Shares"), at a price of Rs. 425/- (Rupees Four Hundred and Twenty Five only) per Equity Share. The buyback will be through the tender offer route on a proportionate basis, in accordance with the Companies Act, 2013 and the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (the - 5E81 Buyback Regulations") and such other circulars or notifications issued by the Securities and Exchange Board of India ("SEBI"). 14 Previous period / year figures have been regrouped / rearranged / reclassified wherever necessary to make it comparable.
Page 13
MSKA Et Associates LLP (Formerly known as MSKA Et Associates) Chartered Accountants SV Tower, No. 27, Floor 4 80 Feet Road, 6th Block, Koramangala Bengaluru 560095, INDIA Independent Auditor's Review Report on standalone unaudited financial results of Medi Assist Healthcare Services Limited for the quarter and year-to-date pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. To The Board of Directors of Medi Assist Healthcare Services Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results of Medi Assist Healthcare Services Limited (hereinafter referred to as 'the Company') for the quarter ended September 30, 2026 and the year-to-date results for the period from April 01, 2026 to September 30, 2026 ('the Statement') attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('the Regulations'). 2. This Statement, which is the responsibility of the Company's Management and has been approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting', prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with relevant rules issued thereunder ('Ind AS 34') and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Page 1 of 2 Registered Office: 602, Rahgja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: .91 22 6974 0200 LLPIN ACT-3789 Ahmedabad I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi I. Kolkata Mumbai I Pune www.inska.in
Page 14
MS K A Et Associates LLP (Formerly known as M S K A Et Associates) Chartered Accountants 5. Emphasis of Matter We draw attention to Note 6 to the accompanying Statement which describes that search and seizure operation was carried out by the Directorate of Enforcement at certain offices of a wholly owned subsidiary and the management's assessment thereof about the consequent impact on the Statement. Our conclusion is not modified in respect of this matter. For MS K A Et Associates LLP (Formerly known as M S K A Et Associates) Chartered Accountants ICAI Firm Registration No.105047W/W101187 Pankaj S Bhauwala Partner Membership No.: 233552 UDIN: 26233552TLHGEI6970 Place: Bengaluru Date: October 30, 2026 Page 2 of 2 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra. India Tel: -91 22 6974 0200 I LLPIN: ACT-3789 Ahmedabad I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi I Kolkata I Mumbai Pune www.mska.in
Page 15
Medi Assist Healthcare Services Limited Corporate Identity Number: L74900MH2000PLC437885 Registered office: AARPEE Chambers. SSRP Building, 7th Floor, Marol Co-operative Industrial Estate Road, Gamdevi, Marol, Andheri East. Mumbai - 400059, India. Telephone .: 91- 8069190000, E-mail: askrdmediassistin: website: www.mediassistin Statement of unaudited standalone financial results for the quarter and six months ended 30 September 2026 (Rs. in millions unless otherwise stated) Sr. No. Particulars Quarter ended Six months ended Year ended 30 September 2026 30 June 2026 30 September 2025 30 September 2026 30 September 2025 31 March 2026 Unaudited Unaudited Unaudited Unaudited Unaudited Audited (refer note 3) 1 Income Revenue from operations 622.50 589.84 607.60 1.212.34 1,044.64 2,254.55 Other income 66.47 70.28 32.64 136.75 56.25 146.31 Total income 688.97 660.12 640.24 1,349.09 1,100.89 2,400.86 2 Expenses Employee benefits expense 127.62 132.00 125.76 259.62 195.35 426.20 Finance costs 4.16 11.12 4.57 15.28 13.26 65.26 Depreciation and amortisation expenses 59.58 48.81 49.95 108.39 100.64 203.22 Other expenses 311.84 291.20 231.78 603.04 454.93 1,018.00 Total expenses 503.20 483.13 412.06 986.33 764.18 1,712.68 3 Profit before exceptional item and tax (1-2) 185.77 176.99 228.18 362.76 336.71 688.18 4 - Exceptional item (refer note 9) 0.52 - - 5 Profit before tax for the period/ year (3-4) 185.77 176.99 228.18 362.76 336.71 687.66 6 Income tax expense: Current tax 47.57 31.78 60.61 79.35 86.85 187.88 Deferred tax expense /(credit) (0.56) 13.69 (8.82) 13.13 (6.73) (20.08) Total income tax expense 47.01 45.47 51.79 92.48 80.12 167.80 7 Profit for the period/ year (5-6) 138.76 131.52 176.39 270.28 256.59 519.86 8 Other comprehensive income/(loss) Items that will not be reclassified subsequently to statement of profit and loss Re-measurement of gains/(losses) on defined benefit plans 0.29 (1.18) (0.02) (0.89) 0.05 1.45 Fair value changes in equity instruments through other comprehensive income (1.18) 6.37 (0.45) 5.19 4.29 (4.61) Income tax relating to items that will not be reclassified to statement of profit and loss (0.11) 0.68 0.06 0.57 (0.65) (0.71) Total other comprehensive income/(loss) for the period/ year, net of tax (1.00) 5.87 (0.41) 4.87 3.69 (3.87) 9 Total comprehensive income for the period/ year (7+8) 137.76 137.39 175.98 275.15 260.28 515.99 10 Paid up equity share capital (face value of Rs. 5 each) 373.51 373.51 353.25 373.51 353.25 373.05 11 Other equity 4,520.83 12 Earnings per equity share (face value of Its. 5 each) (not annualised except for the year ended 31 March 2026) Basic (Rs) 1.86 1.76 2.50 3.62 3.64 7.18 Diluted (Rs) 1.85 1.76 2.49 3.62 3.62 7.18 (Page I of 5)
Page 16
Medi Assist Healthcare Services Limited Corporate Identity Number: L74900MH2000PLC437885 Registered office: AARPEE Chambers, SSRP Building, 7th Floor, Marol Co-operative Industrial Estate Road, Gamdevi, Marol, Andheri East, Mumbai - 400059, India. Telephone .: 91- 8069190000, E-mail: ask(i?mediassist.in: website: www.mediassist.in Unaudited Standalone Statement of Assets and Liabilities (Rs. in millions unless otherwise stated) Sr. No. Particulars As at 30 September 2026 (Unaudited) As at 31 March 2026 (Audited) (refer note 3) A. ASSETS 1 Non-current assets Property, plant and equipment 77.97 82.50 Right-of-use assets 59.79 51.18 Goodwill 3.89 3.89 Other intangible assets 559.32 387.60 Intangible assets under development 36.46 194.40 Financial assets Investments 909.43 826.77 Loans receivables 2,264.00 2,254.52 Other financial assets 31.69 38.39 Income tax assets (net) 37.95 20.73 Deferred tax assets (net) 22.40 35.53 Other non-current assets 0.36 3.11 Total non-current assets 4,003.26 3,898.62 2 Current assets Financial assets Investments 1,067.00 907.11 Trade receivables 313.89 338.87 Cash and cash equivalents 77.53 113.57 Bank balances other than cash and cash equivalents above 189.38 120.00 Other financial assets 76.30 57.64 Other current assets 80.58 67.10 Total current assets 1,804.68 1,604.29 Total assets 5,807.94 5,502.91 B. EQUITY AND LIABILITIES I EQUITY Equity share capital 373.51 373.05 Other equity 4.682.94 4,520.83 Total equity 5,056.45 4,893.88 LIABILITIES 2 Non-current liabilities Financial liabilities Lease liabilities 13.69 39.20 Provisions 34.72 33.67 Total non-current liabilities 48.41 72.87 3 Current liabilities Financial liabilities Lease liabilities 45.86 8.75 Trade payables Total outstanding dues of micro enterprises and small enterprises 25.59 12.08 Total outstanding dues of creditors other than micro enterprises and small enterprises 121.15 110.37 Other financial liabilities 372.43 328.46 Contract liabilities 1.81 0.50 Other current liabilities 41.31 43.73 Provisions 14.80 11.62 Current tax liabilities (net) 80.13 20.65 Total current liabilities 703.08 536.16 Total liabilities 751.49 609.03 Total equity and liabilities 5,807.94 5,502.91 (Page 2 of 5)
Page 17
Medi Assist Healthcare Services Limited Corporate Identity Number: L74900MH2000PLC437885 tegistered office: AARPEE Chambers, SSRP Building, 7th Floor, Marol Co-operative Industrial Estate Road, Gamdevi, Marol, Andheri East, Mumbai - 400059, India. Telephone .: 91- 8069190000, E-mail: ask@mediassist.in: website: www.mediassist.in Unaudited Standalone Statement of Cash Flows Rs in millions unless otherwise stated Particulars For the six months ended 30 September 2026 (Unaudited) For the six months ended 30 September 2025 (Unaudited) Cash flows from operating activities Profit before tax for the period 362.76 336.71 Adjustments: Depreciation and amortisation expenses 108.39 100.64 Allowance for expected credit losses on trade receivables and other receivables 0.06 0.29 Provision for doubtful advances and other receivables 3.74 - Employee stock option compensation expense 12.49 17.28 Finance costs 13.92 12.53 Profit on sale of investments in mutual funds (6.48) (8.59) Interest income (100.17) (31.93) Net gain on financial assets measured at fair value through profit and loss (28.75) - Creditors/provisions no longer required written back (0.25) - Fair value income on derivatives measured through fair value through profit or loss (FVTPL) - (5.61) Loss/ (gain) on disposal of property, plant and equipment (net) 0.01 (0.06) Gain on modification of lease contracts (0.60) - Operating profit before working capital changes 365.12 421.26 Working capital adjustments:. Increase in trade payables 37.38 7.09 (Decrease) in other liabilities (14.03) (168.21) Increase in provisions 3.34 26.08 Decrease/ (increase) in trade receivables 24.92 (171.95) Increase/ (decrease) in other assets (44.62) 146.42 Cash generated from operations 372.11 260.69 Income taxes paid (net) (36.10) (66.58) Net cash flows from operating activities (A) 336.01 194.11 Cash flows from investing activities Purchase of property, plant and equipment, other intangible assets including intangible under development and capital advances (205.96) (190.50) Purchase of non-current investments (76.22) - (Purchase)/ sale of investments in mutual funds (net) (124.66) 378.81 Loan granted (9.48) (500.00) (Investments) in /redemption of bank deposits and other bank balances (69.16) 39.61 Interest received 96.94 33.24 Net cash (used in) investing activities (B) (388.54) (238.84) Cash flows from financing activities Proceeds from issue of shares (including share premium) on exercise of employee stock option 23.96 34.67 Finance costs paid - (3.90) (Repayment) of/ proceeds from borrowings - (16.63) Payment of lease liabilities (7.47) (5.76) Net cash flows from / (used in) financing activities (C) 16.49 8.38 Net increase/ (decrease) in cash and cash equivalents (A+B+C) (36.04) (36.35) Cash and cash equivalents at the beginning of the period 113.57 120.87 Cash and cash equivalents at the end of the period 77.53 84.52 Component of cash and cash equivalents Balances with banks - In current accounts 77.52 84.51 Cash on hand 0.01 0.01 Total cash and cash equivalents at the end of the period 77.53 84.52 (Page 3 of 5)
Page 18
Notes to statement of unaudited standalone financial results for the quarter and six months ended 30 September 2026 I In terms of Regulation 33 of the SE/31 (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the above unaudited standalone financial results of Medi Assist Healthcare Services Limited ("the Company") have been reviewed and recommended by the Audit Committee and approved by the Board of Directors, at their meetings held on 29 October 2026 and 30 October 2026 respectively. These unaudited standalone financial results have been subjected to limited review by the Statutory auditors of the Company and they have issued an unmodified review report on these unaudited standalone financial results. 2 The above unaudited standalone financial results for the quarter and six months ended 30 September 2026 have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015, as amended, ("Ind AS") prescribed under section 133 of Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable. 3 The figures for the year ended 31 March 2026 have been extracted from the general purpose standalone financial statements of the Company for the year ended 31 March 2026 which have been audited by the Statutory auditors of the Company. 4 The Company is engaged in the business of providing health management services which is determined to be the only reportable segment in terms of Ind AS 108 "Operating Segments". 5 On 26 August 2024, Medi Assist Insurance TPA Private Limited ("Transferee Company"/"MAITPA"). the wholly owned subsidiary of the Company had entered into Share Purchase Agreement ("SPA") with Paramount Health Services and Insurance TPA Private Limited ("Transferor Company"/"Paramount TPA") and the Shareholders of the Transferor Company, to purchase 100% equity shares of Transferor Company at a total enterprise value of Rs. 3,118.00 million (Rupees three thousand one hundred eighteen million only) (subject to closing adjustments) which is subject to fulfilment of conditions precedent as defined in the SPA. Regulatory approval from Insurance Regulatory and Development Authority of India (IRDAI) was received on 13 May 2025. On 01 July 2025. MAITPA had completed acquisition of 100% equity stake in Paramount TPA upon payment of the purchase consideration of Rs. 4,124.40 million after closing adjustments as per SPA, and the share transfer was duly executed. Consequently, Paramount TPA became a wholly- owned subsidiary of MAITPA and step-down subsidiary of the Company. 6 During the previous year ended 31 March 2026, on 04 April 2025, the Enforcement Directorate (the 'ID") conducted a search and seizure operation at certain offices of MAITPA, located in Ranchi, Jharkhand. MAITPA is one of the third-party administrators (TPAs) engaged in administering the Ayushman Bharat-linked health scheme in the state of Jharkhand. MAITPA has fully co-operated with the officials during the proceedings and responded to the clarifications and details sought by them. As on the date of issuance of these standalone financial results, MAITPA has not received any communication from the ED regarding the outcome of the search. The Management, after considering all available records and facts known to it, is of the view that there is no adverse impact on the Company, and no adjustment is required in these standalone financial results for the quarter and six months ended 30 September 2026 in this regard. 7 During the year ended 31 March 2026, Paramount TPA, a material step-down subsidiary of the Company, experienced a cyber-security incident that impacted certain systems and services. The incident was fully contained at the Paramount TPA level and did not affect the Company or any of its other subsidiaries. The Company had reported to and intimated the relevant authorities including the stock exchanges of this event. Pursuant to the above, Paramount TPA undertook certain security and business continuity measures including engaging external experts to support system restoration, cyber-forensic activities, etc. Additionally, Paramount TPA had lodged an insurance claim under its cyber-insurance policy for recovery of the eligible costs incurred towards the above incident. The Management, after considering all available information believes no additional adjustments are considered necessary in the standalone financial results for the quarter and six months ended 30 September 2026. 8 The Board of Directors of the Company at its meeting held on 07 August 2025 approved the issuance of equity shares by way of preferential allotment and constitution of Fund Raising Committee. The same was subsequently approved by the Shareholders of the Company at the Extraordinary General Meeting of the Company ('EGM -) held on 04 September 2025. Pursuant to the above approvals, on 10 October 2025, Fund Raise Committee allotted 37,01,000 (Thirty Seven Lakh and One Thousand) fully paid-up equity shares of face value Rs. 5 each at a price of Rs. 535 per share (including a share premium of Rs. 530 per share), for an aggregate consideration of Rs. 1,98,00,35,000 (Rupees One Hundred Ninety-Eight Crore and Thirty-Five Thousand only). The equity shares were allotted on a private placement basis to identified investors as per the details set forth below: Name of Allottees Category Number of shares issued Price at which equity shares are issued (including a share premium of Rs. 530 per share) Consideration received as on the date of allotment (Rs. Millions) Massachusetts Institute Technology Non- promoter 28,90,830 535 1,546.59 238 Plan Associates LLC Non- promoter 8,10,170 535 433.44 Total 37,01,000 1,980.03 The net proceeds from the above were utilized for the purposes as sta ed in the Offer documents other than Rs. 420.26 million which is lying unspent as of 30 September 2026. In accordance with Ind AS 32. the costs that are directly attributable to the above transactions, have been adjusted in equity. (Page 4 of 5)
Page 19
Notes to statement of unaudited standalone financial results for the quarter and six months ended 30 September 2026 9 Effective 21 November, 2025, the Government of India consolidated 29 existing labour regulations into four Labour codes, namely, The Code on Wages. 2019. The Industrial Relations Code, 2020, The Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes'. The New Labour Codes has resulted in material increase in provision for employee benefits on account of recognition of past service costs. Based on the requirements of New Labour Codes, internal management assessment, actuary report and the best information available, accounting standards and in line with ICAI guidance, the Company had assessed and accounted the estimated incremental impact of Rs. 0.52 million as Exceptional Item in the standalone financial results for the year ended 31 March 2026. 10 During the year ended 31 March 2026, MAITPA and Paramount TPA in their respective meeting(s) held on 29 December 2025, had considered and approved the Scheme of Amalgamation/merger of Paramount TPA with MAITPA under the provisions of Section 233 of the Companies Act, 2013 and the rules made thereunder. Subsequently, the Board of Directors of MAITPA and Paramount TPA, at the respective meetings held on 06 February 2026, have approved the withdrawal of the aforementioned merger, and in place of the above, noted and approved the transfer of the TPA business of Paramount TPA w.e.f 01 February 2026, to MAITPA, by way of a Business Transfer Agreement ('BTA'), the BTA constituted transfer of all assets and liabilities relating to the TPA business except for certain balances including treasury assets by way of slump transfer for nil consideration. Further the Board of Directors of MAITPA and Paramount TPA, at the their respective meetings held on 06 February 2026, had considered and approved a Scheme of Merger by Absorption of Paramount TPA ("Transferor Company") with the Company ("Transferee Company") and their respective shareholders and creditors, pursuant to the provisions of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ("Scheme"), subject to receipt of requisite statutory, regulatory and other approvals, as applicable. During the quarter and six months ended 30 September 2026, The Insurance Regulatory and Development Authority of India (IRDAI) has sought certain clarifications in relation to the aforesaid matter, to which MAITPA and Paramount TPA have submitted a joint response. 11 During the year ended 31 March 2026, the Board of Directors of International Healthcare Management Services Private Limited, wholly owned subsidiary, ("IHMS"/"Transferor Company") and Mayfair Consultancy Services India Private Limited, wholly owned subsidiary, ("MCSI"/"Transferee Company") approved, at their respective meetings held on 06 February 2026, a Scheme of Amalgamation/merger of IHMS with MCSI under Section 233 of the Companies Act, 2013, with an appointed date of 01 April 2025. The Scheme was filed with the Regional Director ("RD"). who forwarded the application to the Hon'ble National Company Law Tribunal, Bengaluru Bench ("Hon'ble NCLT"), vide order dated 19 May 2026. under Section 233(5) for its consideration. During the quarter ended 30 June 2026, the Hon'ble NCLT Registry sought additional documents/information, which the Companies have furnished. The matter is pending before the Hon'ble NCLT for issuance of notice and further directions as on date. 12 During the quarter ended 30 June 2026, in accordance with the terms of the Shareholder's Agreement ("SHA"), the Company exercised its contractual option to acquire an additional 31.75% equity stake in Mayfair We Care Limited, which was approved by the Board of Directors vide its meeting held on 24 June 2026. In connection with the proposed acquisition, the Company paid an advance of Rs. 47.17 million on 30 June 2026 and a further sum of Rs. 28.51 million on 01 July 2026 and completed the acquisition of aforementioned stake effective 01 July 2026. Consequently the Group's stake in Mayfair We Care UK is now revised to 91.75%. 13 The Board of Directors of the Company, at its meeting held on 30 October 2026, approved a proposal to buyback up to 11,59,199 fully paid-up equity shares of the Company having a face value of [(Rs 5/- (Five only)] each of the Company ("Equity Shares"), at a price of Rs. 425/- (Rupees Four Hundred and Twenty Five only) per Equity Share. The buyback will be through the tender offer route on a proportionate basis, in accordance with the Companies Act, 2013 and the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (the "SEB1 Buyback Regulations") and such other circulars or notifications issued by the Securities and Exchange Board of India ("SEBI"). 14 Previous period / year figures have been regrouped / rearranged / reclassified wherever necessary to make it comparable. Place: Bengaluru For and on behalf of the Board of Directors Date: 30 October 2026 Medi Assist Healthcare Services Limited CIN: L74900MH2000PLC437885 atish Gidugu CEO and Whole Time Director DIN: 06643677 (Page 5 of 5) Initialed For Identification Purposes Only
Page 20
ANNEXURE B Details as required under Regulation 30 of SEBI Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD/2/1/3762/2026 dated January 30, 2026 Buyback of Equity Shares Sr. No. Particulars Details 1. Number of securities proposed for buyback Buyback of upto 11,59,199 fully paid-up equity shares 2. Number of securities proposed for buyback as a percentage of existing paid-up capital Buyback of upto 11,59,199 fully paid-up equity shares of face value of INR 5/- (Indian Rupees Five only), representing 1.55% (rounded off to two decimal) of the total number of equity shares in the paid-up equity share capital of the Company. 3. Buyback price INR 425/- per equity share 4. Actual securities in number and percentage of existing paid-up capital bought back The actual number of securities and percentage of the existing paid- up capital bought back shall be ascertained following completion of the buyback. 5. Pre & Post shareholding pattern The pre-buyback shareholding pattern as of September 30, 2026 is as under: Category of Shareholder Pre-Buyback* Number of Equity Shares % to the existing equity share capital Promoters & Promoter Group 34,41,836 4.61% Public Shareholders 7,12,60,006 95.39% TOTAL 7,47,01,842 100% *The post buyback shareholding pattern of the Company shall be ascertained and provided following completion of the buyback.